Neuralink: Breakthrough or Marketing Hype?

Neuralink recently received the FDA's Breakthrough Device label for its neural implant aimed at restoring vision to the blind by interfacing with the brain. While this sounds like a monumental achievement, it's important to understand that the Breakthrough Device program merely expedites the review process for promising innovations without guaranteeing approval or effectiveness. Essentially, this label serves more as a marketing badge than a concrete breakthrough at this stage. While there's hope for the technology's potential, it's crucial to remain skeptical and not let flashy terms cloud judgment. Real-world results are still a significant distance away.

Support the show